If you purchased brand or generic Truvada or Atripla directly from the manufacturer, you may receive a payment from a class action settlement.

Under the settlement, Gilead agreed to pay $246,750,000 into a Settlement Fund.

If you are a member of either or both the Direct Purchaser Classes, your legal rights will be affected whether you act or don’t act. Please read the notice carefully.

UPDATE: On January 18, 2024, the Court held the Final Approval Hearing in the Gilead settlement. The Court entered a written Order approving the proposed settlement on January 19, 2024. The Order is posted here.



If you are a member of either or both of the Direct Purchaser Classes, you may file a claim by obtaining and submitting a Claim Form. This is the only way to receive a payment. The deadline is January 1, 2024.


You may write to the Court about why you do not like the Settlement. The objection deadline is December 28, 2023.

Additionally, you may ask to go to the Final Approval Hearing and speak in Court about the fairness of the Settlement. The Final Approval Hearing is scheduled for January 18, 2024 at 1:30pm PT at the United States District Court for the District Court of California, San Francisco Courthouse, Courtroom 5 - 17th Floor, 450 Golden Gate Avenue, San Francisco, CA 94102.

If you object to the Settlement, you are still a member of the Direct Purchaser Classes and you must file a claim to receive a payment. 


If you do nothing, you will not receive any payment. You will be bound by the releases contained in the Settlement and will not be able to file or continue to pursue your own lawsuit.